The goal of the present study was to evaluate the therapeutic potential of expression vectors carrying the "A" fragment of the diphtheria toxin (DT-A) gene under the control of the H19 regulatory sequences in an ovarian carcinoma animal model. This evidence concerns the gene H19 and ovarian carcinoma.